Literature DB >> 30948905

Role of Positron Emission Tomography/Computed Tomography in Preoperative Assessment of Carcinoma Endometrium-a Retrospective Analysis.

Rohini Kulkarni1,2, Rani Akhil Bhat2, Vibhawari Dhakharia2, Kumar Kallur3, Aparna Gangoli4.   

Abstract

PET/CT has made significant inroads into routine oncological practice in recent times. In our study, we aim to determine its value in preoperative assessment of endometrial carcinoma. A retrospective study between January 2011 and March 2016 was conducted; we included all cases of carcinoma endometrium with a preoperative PET/CT scan. PET/CT images were analyzed and correlated with histological findings after surgical staging. A total of 46 cases were analyzed, mean age was 59.8 years, BMI 30.8 kg/m2, and most common histology endometrioid type (69.5%). We correlated PET/CT findings with histopathology as reference standard. PET/CT had a sensitivity of 40%, moderate specificity (75%) and accuracy (71.7%), good NPV (91.2%), but poor PPV (16.7%) for lymph node involvement. A total of 10 (21.7%) cases were detected to have distant metabolically active lesions on PET/CT, seven out of these were positive for malignancy. And 90% of them were either non-endometrioid type or grade two and higher. We found that SUV of primary tumor was significantly higher in patients with deep myometrial invasion (p = 0.018), and high-risk histological type of tumor (p = 0.022), though not statistically significant when lymph nodal involvement (p = 0.9), cervical involvement (p = 0.56), or histological grade (p = 0.84) were considered. Sensitivity and specificity of PET/CT in staging endometrial cancer is not high enough to reliably tailor lymphadenectomy. Although SUV of the primary tumor was significantly higher in patients with deep myometrial invasion and high-risk histological type, it's usefulness in classifying patients into predefined risk groups seems to be limited. However, it is useful in detecting distant metastasis especially in high-grade and non-endometrioid type of tumors. Thus, implementation of PET/CT as a surrogate for surgical staging of endometrial cancer remains enigmatic and is open to further research.

Entities:  

Keywords:  Endometrial carcinoma; Lymphadenectomy; PET/CT; Positron emission tomography/computed tomography

Year:  2018        PMID: 30948905      PMCID: PMC6414595          DOI: 10.1007/s13193-018-0826-7

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  27 in total

Review 1.  18F-FDG PET or PET/CT for detection of metastatic lymph nodes in patients with endometrial cancer: a systematic review and meta-analysis.

Authors:  Ming-Che Chang; Jin-Hua Chen; Ji-An Liang; Kuang-Tao Yang; Kai-Yuan Cheng; Chia-Hung Kao
Journal:  Eur J Radiol       Date:  2012-02-02       Impact factor: 3.528

2.  ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer.

Authors: 
Journal:  Obstet Gynecol       Date:  2005-08       Impact factor: 7.661

3.  Revised FIGO staging for carcinoma of the endometrium.

Authors:  William Creasman
Journal:  Int J Gynaecol Obstet       Date:  2009-04-03       Impact factor: 3.561

4.  Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer.

Authors:  H J Lee; B-C Ahn; C M Hong; B I Song; H W Kim; S Kang; S Y Jeong; S-W Lee; J Lee
Journal:  Nuklearmedizin       Date:  2011-07-05       Impact factor: 1.379

5.  Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  N Colombo; S Carinelli; A Colombo; C Marini; D Rollo; C Sessa
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

Review 6.  PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysis.

Authors:  Maurizia Dalla Palma; Michele Gregianin; Pasquale Fiduccia; Laura Evangelista; Anna Rita Cervino; Giorgio Saladini; Lucia Borgato; Maria Ornella Nicoletto; Vittorina Zagonel
Journal:  Crit Rev Oncol Hematol       Date:  2012-01-13       Impact factor: 6.312

7.  Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer.

Authors:  Kazuhiro Kitajima; Koji Murakami; Erena Yamasaki; Yasushi Kaji; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2009-01-29       Impact factor: 5.315

Review 8.  Magnetic resonance imaging of endometrial carcinoma.

Authors:  Silanath Peungjesada; Priya R Bhosale; Aparna Balachandran; Revathy B Iyer
Journal:  J Comput Assist Tomogr       Date:  2009 Jul-Aug       Impact factor: 1.826

9.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

Authors:  Pierluigi Benedetti Panici; Stefano Basile; Francesco Maneschi; Andrea Alberto Lissoni; Mauro Signorelli; Giovanni Scambia; Roberto Angioli; Saverio Tateo; Giorgia Mangili; Dionyssios Katsaros; Gaetano Garozzo; Elio Campagnutta; Nicoletta Donadello; Stefano Greggi; Mauro Melpignano; Francesco Raspagliesi; Nicola Ragni; Gennaro Cormio; Roberto Grassi; Massimo Franchi; Diana Giannarelli; Roldano Fossati; Valter Torri; Mariangela Amoroso; Clara Crocè; Costantino Mangioni
Journal:  J Natl Cancer Inst       Date:  2008-11-25       Impact factor: 13.506

10.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Authors:  H Kitchener; A M C Swart; Q Qian; C Amos; M K B Parmar
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321

View more
  3 in total

1.  ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

Authors:  Nicole Concin; Carien L Creutzberg; Ignace Vergote; David Cibula; Mansoor Raza Mirza; Simone Marnitz; Jonathan A Ledermann; Tjalling Bosse; Cyrus Chargari; Anna Fagotti; Christina Fotopoulou; Antonio González-Martín; Sigurd F Lax; Domenica Lorusso; Christian Marth; Philippe Morice; Remi A Nout; Dearbhaile E O'Donnell; Denis Querleu; Maria Rosaria Raspollini; Jalid Sehouli; Alina E Sturdza; Alexandra Taylor; Anneke M Westermann; Pauline Wimberger; Nicoletta Colombo; François Planchamp; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2021-02       Impact factor: 4.064

2.  Application of CT and MRI combined with VEGF-C and EGFR in the identification of endometrial cancer stages.

Authors:  Changsong Li; Jingsheng Yu; Zhexiang Fu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  Value of preoperative staging of endometrial carcinoma with contrast-enhanced ultrasonography: A PRISMA compliant meta-analysis.

Authors:  Xiaozhen Tong; Xiaofen Wu; Qiaohong Zhang
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.